Active Pharmaceutical Ingredients (API for Human and Animal) and its
The global pharmaceutical market has an estimated worth of over US$ 1.5 trillion. The market is
divided by regions into Asia Pacific, North America, Europe, Latin America, the Middle East,
and Africa. Out of these, North America alone has an API market revenue of over USD 79.80
billion. Over 70% of the drugs sold in the USA contain APIs and intermediates manufactured
outside the USA.
Hence, API Sourcing plays a significant role in maintaining supply chains in the global
pharmaceutical market. Due to the high price of branded drugs, there is a massive market for
generic drugs in high-cost regions such as the USA, Canada, and Europe.
Indian Pharmaceutical Industry is ranked 4th in the world, of the volume of sales, the estimated
worth of US$ 6 billion every year. The Indian Pharma Industry caters almost 70% of the
domestic demand for bulk drugs. India produces around 20% to 24% of the global generic drugs
and has the Capacity and Technology of complex drug manufacturing.
In API Sourcing, there are three significant criteria involved in decision making, which are:
Quality, Security of supply, and cost. India already has the most significant number of US Food
and Drug Administration (USFDA) standardized manufacturing units outside United States
territory. Further, Indian manufacturers have implemented all the required regulatory policies
and standards required by the FDA to boost their growth. There has been a significant increase in
the number of DMF and CEP filings of Indian manufacturers in recent years.
Pharma companies focus on either drug discovery and development or sales and marketing.
sourcing solves the problem of maintaining supply, allowing pharma companies to invest more
in drug discovery and development. Earlier, outsourcing was based on a country’s capacity to
produce a surplus. Now, the decision is based on the cost-effectiveness of investment and the
speed of the process. This makes API and intermediate sourcing particularly valuable.
Sourcing of APIs and intermediates requires an exceptional understanding of the global
marketplace, trends, and shifts in the market, current market regulations for specific products,
and demands by different organizations such as the FDA, Health Canada, and EDQM and
pricing trends of different APIs and intermediates.
This business poses several challenges, and those companies with secure networking and
sourcing strategies are likely to thrive. APAC has strategically sourced critical APIs and
intermediates based on “Non-Infringement” processes. Proven capability to save 10% to 30% of
the last buying price, we have worked proactively to participate in business planning, supply
chain management of the customer to improve their product mix. Expertise in Pharma Industry
and trustworthy relationship enables us superior negotiation and sourcing of hard to find